03/06/2025

Giovannelli e Associati with White Bridge Investments II on the acquisition of the entire share capital of Cirelli La Collina Biologica S.r.l.

Bridge Investments II, a private equity fund focused on Italian excellence, acquired, through its subsidiary Tenuta Ulisse S.r.l., the entire share capital of Cirelli La Collina Biologica S.r.l., a winery […]
21/05/2025

Giovannelli e Associati with Argos Wityu on the acquisition of Axitea from Stirling Square Capital Partners

The paneuropean private equity group Argos Wityu acquired from Stirling Square Capital Partners the entire share capital of Axitea, leading Italian player in digital surveillance and security services for corporate […]
26/03/2025

Giovannelli e Associati recommended for six practice areas in The Legal 500 EMEA 2025 edition

Legal500 recommended, once again, Giovannelli e Associati as a leading firm in Italy for the following six practice areas: “Banking and finance: Borrower Side”, “Capital Markets: Equity”, “Commercial, Corporate and […]
26/03/2025

Giovannelli e Associati with Axel Johnson International on the acquisition of a majority stake in Airsoft S.r.l.

Axel Johnson International, a Swedish multinational family-owned company operating globally, focused on acquisitions and the development of companies specializing in technical components and industrial solutions, acquired – through its industrial […]
13/03/2025

Giovannelli e Associati with Harcos Capital Partners S.r.l. on the first add-on to the Polo Bullonerie e Viterie Speciali

Harcos Capital Partners S.r.l., through its parent company HCP Fastener Holding S.r.l., acquired 100% of the corporate share capital of Dell’Era Ermanno e Figlio S.r.l., a company operating in the […]
27/02/2025

Giovannelli e Associati with BMG Pharma on the contribution of a business unit to Healthea Licensing S.r.l. and on the subsequent sale of the latter to BioDue

BioDue S.p.A., a subsidiary company of the U.S. fund The Riverside Company, acquired Healthea Licensing S.r.l., a company to which a business unit was contributed by BMG Pharma S.p.A consisting, […]